Tagged biopsies

0

Q&A: The startup aiming to improve cancer diagnoses through AI-based analysis of biopsies

Web content editor Ian Bolland caught up with Avi Veidman, CEO of pathology startup Nucleai which aims to make cancer diagnoses more accurate, accessible and efficient through AI-based analysis of biopsies. Give us an idea of the ‘comprehensive suite of solutions that Nucleai offers? Nucleai provides a comprehensive suite of solutions for cancer biopsies relating to gastro, breast and prostate…

© 2019 Rapid Life Sciences Ltd, a Rapid News Group Company. All Rights Reserved.

Privacy policy

Terms and conditions